Cargando…
Clinical Application of Targeted Next Generation Sequencing for Colorectal Cancers
Promising targeted therapy and personalized medicine are making molecular profiling of tumours a priority. For colorectal cancer (CRC) patients, international guidelines made RAS (KRAS and NRAS) status a prerequisite for the use of anti-epidermal growth factor receptor agents (anti-EGFR). Daily, new...
Autores principales: | Fontanges, Quitterie, De Mendonca, Ricardo, Salmon, Isabelle, Le Mercier, Marie, D’Haene, Nicky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187917/ https://www.ncbi.nlm.nih.gov/pubmed/27999270 http://dx.doi.org/10.3390/ijms17122117 |
Ejemplares similares
-
Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience
por: D’Haene, Nicky, et al.
Publicado: (2018) -
Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers
por: D’Haene, Nicky, et al.
Publicado: (2015) -
Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas
por: D’Haene, Nicky, et al.
Publicado: (2019) -
PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
por: Bienfait, Lucie, et al.
Publicado: (2018) -
VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)